Navigation Links
Vet-Stem, Inc. Founder and CEO Presents at TargetMeeting’s 3rd World Drug Discovery Online Conference
Date:10/24/2013

Poway, California (PRWEB) October 24, 2013

Dr. Robert Harman, Founder and CEO of Vet-Stem, Inc., a Regenerative Veterinary Medicine company in Southern California, presented at TargetMeeting’s 3rd World Drug Discovery Online Conference, October 15-17th, 2013. Topics of the web-based conference covered biotechnology and biopharmaceuticals, gene and cell therapy, as well as research and clinical trials. Target Meeting is a leading online life science conference organizer that proudly does not require any travel from participants.

Participants like Dr. Harman were able to log into a secure conference track to hear live sessions, be part of question and answer forums, and give interactive presentations. Dr. Harman’s presentation was on “The Science and Business of Veterinary Regenerative Medicine,” covering the use of stem cell therapy, types of stem cells, and uses in clinical veterinary medicine.

“Veterinary Regenerative Medicine is ‘a discipline that seeks to replace or regenerate cells, tissue or organs, to restore or establish normal function.’ Stem cell medicines have been used clinically in veterinary medicine in advance of clinical use in human medicine. There are many commercial companies already offering autologous services and allogeneic stem cell medicines globally.” -Dr. Harman.

Dr. Harman explored the science and business of veterinary regenerative medicine, introducing first the two most commonly employed tissue sources of mesenchymal stem cells (MSC), which are adipose (fat) tissue derived stem cells, and bone marrow derived stem cells.

Dr. Harman also discussed the adoption of the value of the human-companion animal bond and the role of animals in improving human health, drawing from his decade of experience providing stem cell therapy for over 10,000 animals at his company, Vet-Stem. Dr. Harman covered the expansion of companies providing pet insurance, as well as the increasing numbers of pet owners who are older and without children at home have driven the demand for safe and effective veterinary stem cell therapy.

About Vet-Stem, Inc.
Vet-Stem, Inc. was formed in 2002 to bring regenerative medicine to the veterinary profession. The privately held company is working to develop therapies in veterinary medicine that apply regenerative technologies while utilizing the natural healing properties inherent in all animals. As the first company in the United States to provide an adipose-derived stem cell service to veterinarians for their patients, Vet-Stem, Inc. pioneered the use of regenerative stem cells in veterinary medicine. The company holds exclusive licenses to over 50 patents including world-wide veterinary rights for use of adipose derived stem cells. In the last decade over 10,000 animals have been treated using Vet-Stem, Inc.’s services, and Vet-Stem is actively investigating stem cell therapy for immune-mediated and inflammatory disease, as well as organ disease and failure. For more on Vet-Stem, Inc. and Veterinary Regenerative Medicine visit http://www.vet-stem.com or call 858-748-2004.

Read the full story at http://www.prweb.com/releases/Vet-Stem/TMonlineconference/prweb11264189.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Former COO and CSO of IDEXX Laboratories, Inc. Joins Board of Directors for Vet-Stem, Inc.
2. Vet-Stem, Inc. Founder and CEO, Robert Harman, DVM, Presents at Prestigious Stem Cell Conference at Case Western Reserve University
3. Vet-Stem, Inc. Founder, Robert Harman, DVM, Invited as Inspirational Speaker for the 6th Annual After the Finish Line Charity Dinner
4. The Veterinary Cooperative (TVC) and Vet-Stem, Inc. Announce an Exclusive Partnership to Offer Regenerative Medicine and Stem Cell Therapy to Over 300 Member Hospitals
5. Vet-Stem, Inc. Founder and CEO, Robert Harman, DVM, Invited to Speak at the Adult Stem Cell Therapy and Regenerative Medicine Conference
6. The Arrow Group of Animal Hospitals in Central Arizona Partners with Vet-Stem, Inc. to Bring Stem Cell Therapy to Their Patients
7. Pets Best Insurance Announces Stem Cell Therapy and Regenerative Veterinary Medicine by Vet-Stem, Inc. Covered by Their Pet Health Insurance
8. Telome Health Co-founder and Nobel Laureate Elizabeth Blackburn Awarded Innovator of the Year
9. Radiotherapy Clinics of Georgias Founder Returns Home to Celebrate Cancer Survivors and Receive Lifetime Achievement Award
10. Founder of National Childrens Leukemia Unveiled Non-Embryonic Stem Cell Treatment Promising Cure for Cancer at GIL 2012: Europe
11. TREVENTIS Corporation Scientific Founder, Donald Weaver, MD, Named Sobey Chair in Alzheimers Disease Research, His Third Endowed Chair
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... , ... May 23, 2017 , ... Cambridge Semantics ... splash at this year’s Bio-IT World Conference and Expo in Boston May ... Lake® 4.0 solution. The Anzo Smart Data Lake is also a finalist for ...
(Date:5/22/2017)... , ... May 22, 2017 , ... Stratevi, a boutique ... to the East Coast. It has opened an office in downtown Boston at 745 ... finding it increasingly more important to generate evidence on the value they provide, not ...
(Date:5/22/2017)... ... 22, 2017 , ... Cancer diagnostics and pathology workflow solution ... the Association for Pathology Informatics Annual Summit at the Wyndham Grand ... Cancer Diagnostic Cockpit and Consultation Portal, Inspirata will present research it led to ...
(Date:5/21/2017)... ... May 20, 2017 , ... CNSDose is a genetically driven, ... process by finding the right antidepressant faster. CNSDose speeds recovery and reduces ... a personalized approach to treatment. , A peer-reviewed and published, 12-week ...
Breaking Biology Technology:
(Date:3/30/2017)... YORK , March 30, 2017 Trends, ... type (physiological and behavioral), by technology (fingerprint, AFIS, iris ... voice recognition, and others), by end use industry (government ... and immigration, financial and banking, and others), and by ... Europe , Asia Pacific , ...
(Date:3/27/2017)... 2017  Catholic Health Services (CHS) has been ... (HIMSS) Analytics for achieving Stage 6 on the ... In addition, CHS previously earned a place in ... electronic medical record (EMR). "HIMSS Analytics ... EMR usage in an outpatient setting.  This recognition ...
(Date:3/23/2017)... -- The report "Gesture Recognition and Touchless Sensing Market by Technology ... Forecast to 2022", published by MarketsandMarkets, the market is expected to be worth ... and 2022. Continue Reading ... ... ...
Breaking Biology News(10 mins):